Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers

Aberrantly methylated DNA fragments were searched for in human pancreatic cancers, using the genome scanning technique: methylation-sensitive-representational difference analysis (MS-RDA). MS-RDA isolated 111 DNA fragments derived from CpG islands (CGIs), and 35 of them were from CGIs in the 5′ regions of known genes. Methylation-specific PCR (MSP) of the CGIs in seven pancreatic cancer cell lines and two pancreatic ductal epithelial cell lines showed that 27 CGIs in the 5′ regions were aberrantly methylated in at least one of the cancer cell lines. Quantitative reverse-transcription–PCR analysis showed that downstream genes of all the CGIs were either not expressed or only very weakly expressed in cancer cell lines with the aberrant methylation. In the pancreatic ductal epithelial cell lines, 18 genes were expressed at various levels, and nine genes were not expressed at all. Treatment of a cancer cell line with a demethylating agent, 5-aza-2′-deoxycytidine, restored the expression of 13 genes, RASGRF2, ADAM23, NEF3, NKX2-8, HAND1, EGR4, PRG2, FBN2, CDH2, TLL1, NPTX1, NTSR1 and THBD, showing their silencing by methylation of their 5′ CGIs. MSP of 24 primary pancreatic cancers showed that all these genes, except for THBD, were methylated in at least one cancer. Some of those were suggested to be potentially involved in pancreatic cancer development and progression.

[1]  D. Shibata,et al.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.

[2]  M. Wigler,et al.  Cloning the differences between two complex genomes , 1993, Science.

[3]  R. Hruban,et al.  Chromosome abnormalities in pancreatic adenocarcinoma , 1994, Genes, chromosomes & cancer.

[4]  R. Hruban,et al.  Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma , 1994, Nature Genetics.

[5]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[6]  Y. Hsu,et al.  Mouse and human neuronal pentraxin 1 (NPTX1): conservation, genomic structure, and chromosomal localization. , 1996, Genomics.

[7]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[8]  Y. Hosoya,et al.  Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Jean-Pierre Julien,et al.  Neurofilaments in health and disease. , 1998, Progress in nucleic acid research and molecular biology.

[10]  J. Cross,et al.  The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis , 1998, Nature Genetics.

[11]  M. Tsao,et al.  Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. , 1998, The American journal of pathology.

[12]  N. Kley,et al.  Isolation of differentially expressed cDNAs from p53-dependent apoptotic cells: activation of the human homologue of the Drosophila peroxidasin gene. , 1999, Biochemical and biophysical research communications.

[13]  D. Takai,et al.  Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis , 2001, Oncogene.

[14]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[15]  Daiya Takai,et al.  Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Paz,et al.  Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. , 2003, Human molecular genetics.

[17]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[18]  C. Qiu,et al.  Allelic imbalance and altered expression of genes in chromosome 2q11–2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine , 2003, Oncogene.

[19]  H. Tsuda,et al.  Reduced Expression of GNA11 and Silencing of MCT1 in Human Breast Cancers , 2003, Oncology.

[20]  D. Takai,et al.  Methylation‐Sensitive Representational Difference Analysis and Its Application to Cancer Research , 2003, Annals of the New York Academy of Sciences.

[21]  Y. Yagi,et al.  Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers , 2003, Oncogene.

[22]  A. Camargo,et al.  Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors , 2004, Oncogene.

[23]  D. Matallanas,et al.  Activation of H-Ras in the Endoplasmic Reticulum by the RasGRF Family Guanine Nucleotide Exchange Factors , 2004, Molecular and Cellular Biology.

[24]  Ericka Stricklin-Parker,et al.  Ann , 2005 .